Latin America and the Caribbean vs Uganda: Proportion of the target population who received the final dose of
Latin America and the Caribbean
69.0%
in 2024
Uganda
95.0%
in 2024
Latin America and the Caribbean rank
4th
Uganda rank
4th
Proportion of the target population who received the final dose of over time
- Latin America and the Caribbean
- Uganda
How they compare
Uganda currently reports 95.0% against 69.0% in Latin America and the Caribbean, a difference of 26.0%.
That makes Uganda's figure about 1.4 times Latin America and the Caribbean's.
The two have swapped places 5 times across 9 shared years of data; in 2016 it was Latin America and the Caribbean ahead.
Latin America and the Caribbean ranks 4th and Uganda ranks 4th of 35 groups.
Across the 2 decades both report, Latin America and the Caribbean averaged higher in 1 and Uganda in 1.
Head to head by decade
| Decade | Latin America and the Caribbean | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 58.0% | 57.2% | 0.8% | Latin America and the Caribbean |
| 2020s | 49.4% | 61.0% | 11.6% | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received the final dose of, Latin America and the Caribbean or Uganda?
- Uganda, at 95.0% against 69.0% in Latin America and the Caribbean as of 2024.
- What is the difference in proportion of the target population who received the final dose of between Latin America and the Caribbean and Uganda?
- 26.0%, with Uganda ahead.
- How many years of comparable data are there for Latin America and the Caribbean and Uganda?
- 9 years are reported by both, from 2016 to 2024.
- How do Latin America and the Caribbean and Uganda rank globally for proportion of the target population who received the final dose of?
- Latin America and the Caribbean ranks 4th and Uganda ranks 4th of 35 groups.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received the final dose of human papillomavirus (HPV) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.